tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Income Statement

Compare
493 Followers

Fulcrum Therapeutics Income Statement

Last quarter (Q4 2024), Fulcrum Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Fulcrum Therapeutics's net income was $-17.66M. See Fulcrum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 80.00M$ 2.81M$ 6.34M$ 19.16M$ 8.82M
Gross Profit
$ 78.41M$ 2.81M$ 3.93M$ 16.65M$ 6.44M
Operating Expenses
$ 101.90M$ 113.47M$ 118.48M$ 100.22M$ 80.43M
Depreciation and Amortization
$ 1.59M$ 2.17M$ 2.41M$ 2.52M$ 2.38M
EBITDA
$ -18.24M$ -108.49M$ -109.72M$ -78.54M$ -69.23M
Operating Income
$ -21.90M$ -110.66M$ -112.56M$ -81.05M$ -71.61M
Other Income/Expenses
$ 12.17M$ 13.33M$ 2.69M$ 207.00K$ 792.00K
Pretax Income
$ -9.72M$ -97.33M$ -109.87M$ -80.85M$ -70.82M
Net Income
$ -9.72M$ -97.33M$ -105.62M$ -78.33M$ -68.44M
Per Share Metrics
Basic EPS
$ -0.17$ -1.59$ -2.35$ -2.22$ -2.70
Diluted EPS
$ -0.17$ -1.59$ -2.35$ -2.22$ -2.70
Weighted Average Shares Outstanding
61.98M 61.31M 44.99M 35.36M 25.35M
Weighted Average Shares Outstanding (Diluted)
61.98M 61.31M 44.99M 35.36M 25.35M
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis